APA (7th ed.) Citation

Kazemi, M. S., Rezaei Kanavi, M., Kazemi-Lomedasht, F., Ahangari Cohan, R., Mahjoobi, G., Safi, S., . . . Behdani, M. (2026). Ocular Safety of Intravitreal Engineered Humanized Anti-VEGF Nanobody and Its Efficacy in the Attenuation of Choroidal Neovascularization and Associated Subretinal Fibrosis. Biomolecules (2218-273X), 16(6), 772. https://doi.org/10.3390/biom16060772

Chicago Style (17th ed.) Citation

Kazemi, Mir Salar, et al. "Ocular Safety of Intravitreal Engineered Humanized Anti-VEGF Nanobody and Its Efficacy in the Attenuation of Choroidal Neovascularization and Associated Subretinal Fibrosis." Biomolecules (2218-273X) 16, no. 6 (2026): 772. https://doi.org/10.3390/biom16060772.

MLA (9th ed.) Citation

Kazemi, Mir Salar, et al. "Ocular Safety of Intravitreal Engineered Humanized Anti-VEGF Nanobody and Its Efficacy in the Attenuation of Choroidal Neovascularization and Associated Subretinal Fibrosis." Biomolecules (2218-273X), vol. 16, no. 6, 2026, p. 772, https://doi.org/10.3390/biom16060772.